The Federal Antimonopoly Service spoke about the nuances of establishing requirements for medical products in the case of their purchase under Federal Law No. 44

16 June 2023, Friday

The Antimonopoly Agency reported that the class of potential risk of a medical device is not a therapeutically or diagnostically significant characteristic. Therefore, the inclusion in the description of the object of purchase of requirements on compliance of medical devices with a certain class of potential risk of use may lead to an unjustified reduction in the number of procurement participants and does not comply with the Law on the Contract System and the Law on Protection of Competition.

Document: Letter of the FAS of Russia dated May 16, 2023 N TН/37551/23